Advertisement

YM443 in Subjects With Functional Dyspepsia

21:05 EDT 19th May 2013 | BioPortfolio

Summary

The primary objective of this study will be to characterize the dose response profile of YM443 in subjects with functional dyspepsia (FD) to enable the selection of doses for the Phase 3 clinical trial.

Study Design

Allocation: Randomized, Control: Placebo Control, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Conditions

Indigestion

Intervention

YM443

Location

Dr. Suresh Karne
Huntsville
Alabama
United States
35802

Status

Completed

Source

Astellas Pharma Inc

Results (where available)

View Results

Links

Medical and Biotech [MESH] Definitions

Lactose Intolerance

The condition resulting from the absence or deficiency of LACTASE in the MUCOSA cells of the GASTROINTESTINAL TRACT, and the inability to break down LACTOSE in milk for ABSORPTION. Bacterial fermentation of the unabsorbed lactose leads to symptoms that range from a mild indigestion (DYSPEPSIA) to severe DIARRHEA. Lactose intolerance may be an inborn error or acquired.

Clinical Trials [ 2 Associated Clinical Trials listed on BioPortfolio]

A Study to Evaluate the Effect of Repeat Oral Doses of YM443 on Cardiac Repolarization in Healthy Adults

This study evaluates whether YM443 causes any changes in the electrocardiogram of healthy adults.

Inhibition of Gastric Acid is the Key to Satisfactory Relief of Symptoms With Esomeprazole in NUD Patients

Inhibition of gastric acid is the key to satisfactory relief of symptoms with esomeprazole in NUD patients

PubMed Articles [ 18 Associated PubMed Articles listed on BioPortfolio]

Inducing indigestion: companies embrace autophagy inhibitors.

Self-reported health problems, health care utilisation and unmet health care needs of elderly men and women in an urban municipality and a rural area of Bhaktapur District of Nepal.

The study aimed to identify the felt common health problems, utilisation of health services and unmet needs of urban and rural elderly people of Bhaktapur district, Nepal. It was a cross sectional pop...

Acotiamide (Z-338, YM443), a new drug for the treatment of functional dyspepsia.

Introduction: Functional dyspepsia (FD) is a highly prevalent condition with a major impact on quality of life and high socio-economic and healthcare costs. To date, no treatment of established effica...

Prokinetic and laxative effects of the crude methanolic extract of Viola betonicifolia whole plant in rodents.

BACKGROUND: The present study was aimed to provide ethnopharmacological basis for the medicinal use of Viola betonicifolia whole plant in indigestion and constipation. METHODS: Mice were used in in-vi...

Association between gastrointestinal symptoms and health-related quality of life after heart transplantation.

BACKGROUND:: Heart transplantation (HTx) ameliorates the self-perceived health-related quality of life (HRQoL) of patients with terminal heart disease; gastrointestinal (GI) symptoms, due to obligator...

More From BioPortfolio on "YM443 in Subjects With Functional Dyspepsia"

Search BioPortfolio: